272 related articles for article (PubMed ID: 28446712)
1. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy.
Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C
Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712
[TBL] [Abstract][Full Text] [Related]
2. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment.
Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C
J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
[TBL] [Abstract][Full Text] [Related]
4. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
5. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epithelial-mesenchymal transition via sonic hedgehog/glioma-associated oncogene homolog 1 signaling pathway in peritoneal mesothelial cells.
Xu Y; Wang J; Ding H
Cell Biol Int; 2020 Aug; 44(8):1691-1700. PubMed ID: 32298032
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
8. Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines.
Gao H; Song Q; Yang J; Yu S; Zhao J; Yu G
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):104-108. PubMed ID: 28886322
[TBL] [Abstract][Full Text] [Related]
9. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
[TBL] [Abstract][Full Text] [Related]
10. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide.
Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW
Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo.
Du WZ; Feng Y; Wang XF; Piao XY; Cui YQ; Chen LC; Lei XH; Sun X; Liu X; Wang HB; Li XF; Yang DB; Sun Y; Zhao ZF; Jiang T; Li YL; Jiang CL
CNS Neurosci Ther; 2013 Dec; 19(12):926-36. PubMed ID: 24165291
[TBL] [Abstract][Full Text] [Related]
12. Differential role of Pax6 and its interaction with Shh-Gli1-IDH2 axis in regulation of glioma growth and chemoresistance.
Farheen S; Ahmed SP; Mariyath P M M; Kausar T; Hoda MF; Arif SH; Nayeem SM; Ali A; Chosdol K; Shahi MH
J Biochem Mol Toxicol; 2023 Feb; 37(2):e23241. PubMed ID: 36205257
[TBL] [Abstract][Full Text] [Related]
13. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling.
Lan T; Zhao Z; Qu Y; Zhang M; Wang H; Zhang Z; Zhou W; Fan X; Yu C; Zhan Q; Song Y
Oncotarget; 2016 Aug; 7(34):55555-55571. PubMed ID: 27487130
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
15. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X
Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575
[TBL] [Abstract][Full Text] [Related]
16. Essential role of Gli proteins in glioblastoma multiforme.
Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S
Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423
[TBL] [Abstract][Full Text] [Related]
17. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
[TBL] [Abstract][Full Text] [Related]
18. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
[TBL] [Abstract][Full Text] [Related]
19. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
Yu G; Wu F; Wang E
Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861
[TBL] [Abstract][Full Text] [Related]
20. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]